Gut microbiota is essential for the development of the gastrointestinal system, including the enteric nervous system (ENS). Perturbations of gut microbiota in early life have the potential to alter neurodevelopment leading to functional bowel disorders later in life. We examined the hypothesis that gut dysbiosis impairs the structural and functional integrity of the ENS, leading to gut dysmotility in juvenile mice.
Introduction
The naturally occurring commensal microbiota consists of about 10 14 bacterial cells belonging to approximately 500-1000 species that symbiotically colonize the human gut (Foster and McVey Neufeld, 2013) . The individual composition of the microbiota is constantly altered by several factors including, but not limited to, genetics, age, sex, diet, medicines and lifestyle. In general, the interactions between commensal microbiota and its host are beneficial. The intestinal microbiota is an indispensable organ for the homeostasis of the host, participating in nutrient processing and production of essential compounds, such as short-chain fatty acids and some vitamins, and contributing to the maturation of the gastrointestinal (GI) system and shaping the immune system. Interestingly, the total metabolic capacity of the commensal microbiota is comparable to the metabolic capacity of the liver (Foster and McVey Neufeld, 2013; Sommer and Bäckhed, 2013) . Several studies carried out in animal models have underlined the bottom-up effects of the enteric microbiota on the development and maturation of the enteric nervous system (ENS) (Hyland and Cryan, 2016) . In normal conditions, the intestinal epithelial barrier and mucous layer separate the ENS, which comprises two distinct interconnected networks of neuronal and glial cells innervating all the GI tract -the submucosal and myenteric plexusesfrom the microbiota (Furness, 2012; Coelho-Aguiar et al., 2015) . However, enteric neurons and glial cells can sense microbes through pattern recognition receptors, such as the toll-like receptors, TLRs) (Anitha et al., 2012; Brun et al., 2013) and other neurochemical receptors as well as through microbial-derived components, microvescicles, neuroactive metabolites or mucosal elements (e.g. enteroendocrine-cell derived mediators) (Hyland and Cryan, 2016) . Recently, the effects of gut microbiotamediated signalling on ENS function has been investigated in many different animal models, from animals fed with specific dietary treatments to transgenic animals or germfree rodents. Most of these studies showed that perturbations of microbial communities may affect postnatal ENS development, inducing adaptive changes in both enteric neurons and glia . Such microbiota-induced ENS plasticity may not only influence GI functions (Kabouridis and Pachnis, 2015) but can also potentially lead to CNS responses, via gut-to-brain signalling (Borre et al., 2014) .
Indeed, the hypothesis that alterations in gut microbiota may lead to the onset of acute or chronic diseases, both in the gut and in the brain, has been proposed by several groups (Foster and McVey Neufeld, 2013; Kabouridis and Pachnis, 2015; Hyland and Cryan, 2016) . Specifically, several studies have shown that changes in microbiota composition may be related to functional or psychiatric disorders such as irritable bowel syndrome (IBS) (Kennedy et al., 2014) , autism and cognitive impairment (Mayer et al., 2014; Fröhlich et al., 2016) . These findings support the existence of a local mutual interaction between the enteric microbiota and the ENS, but also an indirect influence of CNS function, via activation of neuroendocrine and metabolic pathways, suggesting that the relative abundance and diversity of the various microbe constituents is essential for the development and maturation of host CNS and ENS.
In particular, the incidence of paediatric IBD is increasing worldwide with a dramatic rise of Crohn's disease, involving especially those children previously exposed to antibiotic courses (Ungaro et al., 2014) . Because adolescence and early adulthood are critical times for the development and maturation of the nervous system and because the ileum represents the intestinal segment mostly affected by Crohn's disease, we have, here, investigated the effects of gut dysbiosis induced by antibiotics on the morphology and function of the ENS in juvenile mice.
Methods

Animals
All animal care and experimental procedures were approved by the Animal Care and Use Ethics Committee of the University of Padova and by the Italian Ministry of Health (authorization number: 1142/2015-PR) and were performed in accordance with national and EU guidelines for the handling and use of experimental animals. Animal studies are reported in compliance with the ARRIVE guidelines (Kilkenny et al., 2010; McGrath and Lilley, 2015) .
Juvenile male C57BL/6 J mice (3 ± 1 weeks old, body weight 18 ± 1 g, Charles River Laboratories, Italy) were housed in individually ventilated cages (four animals per cage) at the conventional animal facility of the Department of Pharmaceutical and Pharmacological Sciences of the University of Padova, under controlled environmental conditions (temperature 21 ± 1°C; relative humidity 60-70%) with free access to standard laboratory chow and tap water and maintained at a regular 12/12 h light/dark cycle.
Treatments
To induce gut dysbiosis in mice, we used a previously established pharmacological model, which reproduces a germ-free-like phenotype (Reikvam et al., 2011; Josefsdottir et al., 2017) . Briefly, a cocktail of broad spectrum antibiotics (50 mg·kg À1 vancomycin, 100 mg·kg À1 neomycin, 100 mg·kg À1 metronidazole and 100 mg·kg À1 ampicillin) was administered to mice every 12 h for 14 days by oral gavage (100 μL per mouse), using a stainless steel feeding tube without prior sedation of the animals (Reikvam et al., 2011; Brun et al., 2013) ; this constituted the ABX-treated group. Control (CNTR) mice were treated similarly with vehicle (tap water). Animals were randomized to treatment groups. To normalize gut microbiota, mouse colonies from both groups were housed in the same room and generally in the same cages and maintained by the same personnel. In a sub-group pf mice, the TLR2 agonist Pam3CysSerLys4 (Pam3CSK4; Invivogen, San Diego, USA), was administered (i.p.; 2 mg·kg À1 in 0.9% saline) to ABX-treated mice for seven consecutive days during the second week of antibiotic treatment. At the end of procedures, animals were killed by cervical dislocation. All the following analytical procedures were conducted blindly.
Bile acids extraction and HPLC-MS analysis
The concentration of the bile acids, cholic acid (CA) and taurocholic acid (TCA) in the small intestinal lumen was evaluated by LC quadrupole time-of-flight MS (LC-QTOF-MS). Stool samples (50 mg) were collected 12 h after the last antibiotic treatment from the small intestinal lumen, homogenized and extracted with 1 mL acetonitrile and then centrifuged for 10 min at 12 000 × g. Supernatants were diluted 1:10 with a mobile phase (water and acetonitrile, 50:50 v/v, acidified with 5 mM ammonium acetate). Randomized samples were analysed by LC-QTOF-MS with a Ultra-high performance liquid chromatography (UHPLC) system (Agilent Series 1200; Agilent Technologies, Palo Alto, CA, USA), consisting of vacuum degasser, auto-sampler, a binary pump and a column oven coupled to QTOF-MS mass analyser (Agilent Series 6520; Agilent Technologies). The eluent flow rate was 0.25 mL·min À1 through the analytical column Kinetex C-18 (2.6 μm, 100 × 2.1 mm i.d., Phenomenex, Italy) thermostated at 18°C. The mobile phase gradient profile was as follows (t in min): t0, B = 0%; t4, B = 100%; t6, B = 100%; t7, B = 0%; t14, B = 0%. The QTOF system was equipped with an ESI, operating in dual ESI mode and negative acquisition (capillary voltage, 3500 V; nebulizer pressure, 30 ψ; drying gas, 10 L·min
À1
; gas temperature, 350°C; fragmentor voltage, 170 V; skimmer 65 V). Centroid full scan mass spectra were recorded over the range 50-2000 m/z with a scan rate of 1 spectra·s
. Tandem MS fragmentation of each pseudomolecular ion [M-H] À was performed in target MS mode, setting at least 20 scans at scan rate of two scan·s À1 with a peak width of 4 amu and retention time tolerance of 1 min. Standard solutions of TCA and CA (0.5 μg·mL
) were used in flow injection analysis for the optimization of the fragmentor voltage and collision energies (Table 1) . A QTOF calibration was daily performed with the manufacturer's solution. For all chromatographic runs, the ionic signal at m/z 112.9856 referable to formic acid was set as lock mass. Mass spectra acquisition and data analysis were performed with Masshunter Workstation B.07.00 software (Agilent Technologies). All analyses performed showed a mass accuracy better than 5 ppm, allowing the correct identification of the target bile acids. Quantitation was achieved by plotting the analyte area, corresponding to the extracted ion chromatogram with a window span of 20 ppm of the [M-H] À . To avoid inaccuracies due to matrix effects, the standard addition method with least squares regression was carried out, by adding to each sample the standard analytes in duplicate at three concentration levels within the range of 50-4000 μg·g À1 for TCA and 750-6000 μg·g À1 for CA. Limits of detection corresponding to an S/N of 3 were assessed from diluting the lowest quantified concentration of the real samples (Table 1) .
Macroscopic and histological assessment
Mice were killed by cervical dislocation, and the whole intestine (from stomach to anus) was excised. The entire length of the stomach, small intestine and caecum was measured. The weight of caecum with its contents was also measured. Ileum, caecum and stomach specimens, after being fixed in 10% buffered formalin, were embedded in paraffin and cut into 4 μm sections. Tissue sections were then stained with haematoxylin and eosin (H&E). Smooth muscle thickness and lumen diameter of the stomach, ileum and caecum were analysed in 10 H&E sections for each group (Dall'Olmo et al., 2014) .
Gastrointestinal transit
The GI transit was assessed by evaluating the distribution through the bowel of orally gavaged FITC-labelled dextran (FITC-dextran, 70 kDa; 25 mg·mL À1 in 0.9% saline solution).
After 30 min, mice were randomly and killed, and the GI tract from stomach to distal colon was collected and placed into Krebs solution. The stomach and caecum were analysed separately while the small intestine and the colon were divided into 10 and 3 segments of equal length respectively. Luminal contents from each segment were collected and cleared by centrifugation (10 000 × g for 10 min at 4°C). FITC-dextran intensity of each segment was measured fluorimetrically at 492/521 nm (Victor, PerkinElmer; Wallac Instruments, Turku, Finland). The transit of FITC-dextran along the GI tract was determined by calculating the percentage fluorescence for each segment and the geometric centre (GC) for the distribution of the fluorescent probe using the following equation: GC = Σ (% of total fluorescent signal per segment × segment number)/100 .
Pellet frequency and faecal water content
Faecal pellet output was examined daily at a fixed time in CNTR and ABX mice as previously described (Li et al., 2006) . Randomized mice were individually placed in a novel environment (clean cage) and observed for 60 min. The number of pellets per mouse was recorded and weighed (wet weight). Pellets were subsequently dried overnight at 65°C and reweighed until achieving a constant weight (dry weight). Water content was calculated as the difference between the wet weight and dry weight .
In vitro contractility studies
Contractility studies were performed as previously described (Giron et al., 2008; Brun et al., 2013; Zoppellaro et al., 2013) . Segments (1 cm in length) of mouse distal ileum, proximal to the ileocaecal junction, were isolated and mounted along the longitudinal axis in organ baths containing 10 mL of After 45 min equilibration, ileal segments were stretched passively to an initial tension of 0.5 g and brought to their optimal point of length-tension relationship using 1 μM carbachol Zoppellaro et al., 2013) . Ileal segments were treated with carbachol to study cholinergic effects or with 60 mM KCl solution to elicit depolarizationinduced contraction. After the equilibration period, concentration-effect curves to carbachol (0.001-100 μM) were obtained cumulatively and plotted into a nonlinear regression model (fitted to a sigmoidal equation) to calculate EC 50 and maximal tension (Emax) values. Neuronally mediated contractions were obtained through electrical field stimulation (EFS, 0-40 Hz; 1 ms pulse duration; 10 s pulse-trains, 40 V) using platinum electrodes connected to an S88 stimulator (Grass Instrument, Quincy, MA, USA). In order to establish NANC nerve stimulation, both guanethidine (1 μM) and atropine (1 μM) were added to Krebs solution and ileal tissues were allowed to equilibrate for 1 h prior to EFS stimulation. Under NANC conditions, the effects of the non-selective NOS inhibitor L-NAME, 100 μM; preincubation time = 20 min) or the inducible NOS (iNOS) inhibitor 1400 W (10 μM; preincubation time = 20 min) were recorded on 10 Hz-EFS-induced on-relaxations. In order to evaluate the influence of tachykininergic neurotransmission on ileal contraction, the 10 Hz EFS-mediated tachykininergic offresponse was assessed in presence of 100 μM L-NAME and 10 μM L732138 (NK 1 receptor antagonist) under NANC conditions. Contractile responses were expressed as g tension·per g dry tissue weight of ileal segments.
Under NANC conditions, EFS induced a primary onrelaxation of ileal full thickness segments that was calculated as AUC and normalized per g dry tissue weight to allow comparisons between tissue samples. However, it should be considered that the obtained quotient having the dimension 'minutes' does not have the significance of an average duration, as previously described (Currò et al., 2002) . The effect of ABX-induced changes and/or in vitro pharmacological treatment on EFS-induced inhibitory responses was expressed as percentage relaxations with respect to values obtained in CNTR preparations (Zizzo et al., 2003) .
Histochemical analysis of acetylcholinesterase (AChE) and immunohistochemical analysis of choline acetylase (ChAT) in ileal whole-mount preparations Distal ileum 10 cm segments were filled with fixative solution (4% paraformaldehyde in PBS) for 1 h at room temperature. Using a dissecting microscope, whole-mount preparations consisting of the longitudinal muscle with the myenteric plexus attached (LMMPs) were prepared as previously described For ChAT immunohistochemistry, LMMPs from CNTR and ABX mice were washed in PBT (PBS with 0.2% Triton X-100) for 45 min with gentle shaking. After blocking nonspecific sites with PBT containing 2% BSA for 1 hour at room temperature, LMMPs were incubated with ChAT primary antibody (Supporting Information Table S1 ) diluted in PBT/BSA 2% overnight at room temperature. The following day, LMMPs were washed for 45 minutes in PBT and incubated with secondary antibody (Supporting Information Table S1 ) for 2 hours at room temperature. After three subsequent 15-minutes washes with PBT, LMMPs were mounted on glass slides using a Mowiol Mounting Medium. Images were acquired using a Nikon D-Eclipse C1 confocal microscope (Nikon Instruments, Florence, Italy) equipped with an oilimmersion Nikon Plan-Apo 60×/1.4 objective (see below). Images were captured at identical acquisition exposure-time conditions and thresholded to allow ImageJ software (version 1.48a) to select and measure only ChAT stained segments. In ileal LMMPs, changes in the immunoreactivity for ChAT were assessed by analysing the density index of labelling per myenteric ganglia area (6 animals per group, 20 fields per preparation at 60× magnification).
Immunohistochemistry on ileal whole-mount preparations
LMMPs from CNTR and ABX mice were gently stretched and pinned down on a wax support as previously described and washed in PBT (PBS with 0.2% Triton X-100) for 45 min with gentle shaking. For substance P (SP) immunostaining, the excised tissue was initially incubated for 4 h in Krebs solution, bubbled with 95% O 2 and 5% CO 2 containing colchicine (0.1 g·L À1 ) in order to enhance the immunofluorescence of SP + neurons (Messenger and Furness, 1990) . After blocking non-specific sites with PBT containing 2% BSA for 1 h at room temperature, LMMPs were incubated with primary antibodies (Supporting Information Table S1 ) diluted in PBT/BSA 2% overnight at room temperature. The following day, LMMPs were washed for 45 min in PBT and incubated with secondary antibodies (Supporting Information Table S1 ) for 2 h at room temperature. After three subsequent 15 min washes with PBT, LMMPs were mounted on glass slides using a Mowiol Mounting Medium. Negative controls were obtained by incubating sections with isotype-matched control antibodies at the same concentration as primary antibody and/or pre-incubating each antibody with the corresponding control peptide (final concentration as indicated by manufacturer's instructions).
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Immunohistochemistry on ileal frozen sections
Immunofluorescence was performed on distal ileum frozen tissues (0.5 cm segments) embedded in optimal cutting temperature (OCT) Mounting Medium and sectioned (7 μm-thick) with a cryostat-microtome (Leica CM 1850 UV, Milan, Italy). The sections were mounted onto Superfrost Plus slides and analysed by immunohistochemistry as previously described Antonioli et al., 2014a; Antonioli et al., 2014b) . Briefly, ileal sections from CNTR and ABX mice were fixed for 15 min with 4% paraformaldehyde in PBS, washed in Tris-buffer saline (TBS) and incubated with 0.05 M NH 4 Cl. Ileum samples were permeabilized and blocked with a solution of TBS containing 2% BSA and 0.3% Triton X-100 for 1 h. Then, ileal frozen sections were incubated with the primary antibodies (Supporting Information  Table S1 ) optimally diluted in TBS with 0.5% BSA for 2 h at room temperature. Immunocomplexes were visualized by incubating samples with the corresponding secondary antibodies (Supporting Information Table S1 ) for 1 h at room temperature. Nuclei were stained with TOTO-3 iodide (1:500, Thermo Fisher Scientific, Milan Italy), added together with the secondary antibodies. Negative controls were obtained as described in the previous section titled immunohistochemistry on ileal whole-mount preparations. Robinson et al., 2016) . In ileal LMMP whole-mount preparations changes in the immunoreactivity for S100β, ChAT and TLR2 were assessed by analysing the density index of labelling per myenteric ganglia area (six animals per group, 20 fields per preparation at 60× magnification). Images were captured at identical acquisition exposuretime conditions and thresholded to allow ImageJ software (version 1.48a) to select and measure only stained segments. In ileal cryosections, changes in SP and TLR2 immunoreactivity were evaluated by calculating the density index of labelling per tissue area, as previously described (StenkampStrahm et al., 2013) .
Acquisition and analysis of images
Western immunoblot analysis
Total proteins from mouse ileal samples were extracted in RIPA buffer (150 mM NaCl, 50 mM Tris-HCl, 0.25% wt·vol À1 sodium deoxycholate, 0.1% Nonidet P-40, 100 μM NaVO 4 , 1 mM NaF, 1 mM phenylmethylsulfonyl fluoride, 10 μg·mL À1 aprotinin, 10 μg·mL À1 leupeptin). Particulate material was removed by centrifugation. Proteins were separated by SDS PAGE and then transferred to nitrocellulose membrane. Membranes were then blocked for 1 h with 5% non-fat dried milk in PBS at room temperature and probed with the following primary antibodies: rabbit polyclonal anti-mouse nNOS (1:500; Thermo Fisher Scientific, Milan, Italy) and mouse monoclonal anti-human β actin (1:10 000) over night at 4°C. After repeated washings with 0.1% Tween-20 in TBS, membranes were incubated with the proper secondary antibodies, conjugated with horseradish peroxidase. The immunoreactive bands were visualized using enhanced chemiluminescence (ECL, Millipore, Milano, Italy) . Experiments were performed at least four times for each different preparation. Signal intensity of immunoreactive bands was analysed by the Quantity One software (Bio-Rad Laboratories Srl) and expressed as intensity * mm 2 (INT * mm 2 ).
Data and statistical analysis
The data and statistical analysis in this study comply with the recommendations on experimental design and analysis in pharmacology (Curtis et al., 2015) . All the experiments were analysed by investigators blinded to the treatments. All data are expressed as mean ± SEM, except for the GC, which was presented as median, interquartile range and minimum-maximum. Statistical significance was calculated with the paired or unpaired Student's t-test for two-sample comparisons, one-way ANOVA followed by Newman-Keuls post hoc test for multiple comparison, two-way ANOVA followed by Bonferroni's multiple comparison test for post hoc analysis or the non-parametric Mann-Whitney's U-test for independent variables using GraphPad Prism 3.03 (San Diego, CA, USA). The differences between groups were considered significant when P <0.05; 'N' values indicate the number of animals. Post hoc tests were run only if F achieved P < 0.05 and there was no significant variance inhomogeneity.
Materials
Unless otherwise specified, all chemicals were obtained from Sigma Aldrich (Milan, Italy) and were of the highest available analytical grade. OCT was purchased from Kaltek (Padua, Italy), PFA was from Electron Microscopy Sciences-Società Italiana Chimici (Rome, Italy), Triton-X-100 was from Applichem (Milan, Italy), TRIzol was from Invitrogen (Milan, Italy) and DNase Free was from Ambion (Milan, Italy).
Results
Antibiotic exposure induces a germ-free-like phenotype
Mice orally treated with the antibiotic cocktail for 14 days (ABX-treated mice) showed no differences in the percentage of weight gain (+8.9 ± 1.3%) compared to control (CNTR) mice (+8.4 ± 1.2%, N = 20 mice per group). ABX-treated mice displayed a significant increase in caecum weight (N = 5 mice per group; Supporting Information Figure S1A , B), associated with a significant reduction of spleen weight (N = 5 mice per group; Supporting Information Figure S1C ). Histological analysis of intestinal sections showed a significant increase of the thickness of the muscularis externa in the stomach, ileum and caecum of ABX mice compared to CNTR animals. However, the antibiotic treatment affected only the caecum diameter and length, not those of the gastric and ileal lumen ( Table 2 ). These findings are in agreement with other reports showing the occurrence of macroscopic changes in the intestine of germ-free or antibiotic-treated mice (Reikvam et al., 2011; Grasa et al., 2015; Ge et al., 2017) .
Gastrointestinal motility is impaired in antibiotic-treated mice
Studies in germ-free animals have shown impaired intestinal transit and motor function (Barbara et al., 2005) . In juvenile mice, antibiotic-induced microbiota dysbiosis induced a significant decrease of GI transit, as shown by the higher content of the non-absorbable FITC-labelled dextran in the upper part of the GI tract ( Figure 1A) . Accordingly, ABX-treated mice displayed a significant reduction of the GC compared with that of CNTR mice (N = 10 mice per group; Figure 1B ) and delayed gastric emptying, as shown by a 4.5-fold increase in the gastric fluorescent probe levels (N = 10 mice per group; Figure 1C ). The delay of GI transit in ABX-treated mice was paralleled by a significant reduction in stool expulsion frequency (N = 15 mice per group; Supporting Information Figure S2A ), evaluated during 1 h collection period, and by a decrease of both dry and wet pellet weights and by an increase of faecal water content (N = 15 mice per group; Supporting Information Figure S2B ,C), suggesting the presence of constipation and altered intestinal water secretion. In agreement with other studies (Kuribayashi et al., 2012) , the analysis of the profile of bile acids in the small intestine faecal content of ABX-treated mice revealed around 3.5-fold increase in TCA, whereas CA decreased to below detectable levels (N = 5 mice per group; Figure 1D ), suggesting that the production of CA, following the deconjugation of TCA by enterobacteria, was strongly impaired by antibiotic-induced microbiota dysbiosis.
Antibiotic-induced microbiota dysbiosis causes morphological abnormalities in the architecture of the myenteric plexus of juvenile mice Development of the intestinal microbiota is a key dynamic process in the first years of life, a critical stage for ENS development and maturation Borre et al., 2014) . Changes in microbiota composition and/or signalling are known to influence ENS morphology Hyland and Cryan, 2016) . In the myenteric plexus of ABXtreated mouse ileum, the numbers of HuC/D-stained neurons were significantly lower than in CNTR mice (N = 6 mice per group,; Figure 2A , B). In addition, antibiotic treatment induced distortion of enteric glial cell (EGC) processes within myenteric ganglia, as shown by glial fibrillary acidic protein (GFAP) + labelling, and a marked increase of S100β density index (by 1.4-fold, compared with CNTR, N = 6 mice per group; Figure 2C -E).
Antibiotic-induced microbiota dysbiosis alters excitatory neuromuscular contractility
As longitudinal muscle contractile activity underlies the preparative phase of the peristaltic reflex and is synchronous with circular muscle contraction during peristalsis, changes in its efficiency may influence the whole propulsive bowel activity (Smith and Robertson, 1998) . The effects of antibiotic treatment on neuromuscular function were thus examined in vitro by measuring tension changes in isolated ileal preparations. Ileal segments of ABX-treated mice displayed spontaneous contractile activity consisting of phasic contractions with an amplitude of 210 ± 12.3 mg and a frequency of 32.6 ± 0.2 cpm, with no differences from those in CNTR mice (amplitude = 234 ± 13.2 mg and frequency = 32.4 ± 0.3 cpm, N = 20 mice per group). To evaluate changes in the excitatory neuromuscular response following antibiotic treatment, cumulative concentration-response curves to the non-selective cholinergic agonist, carbachol were performed. Ileal segments from ABX-treated mice showed a significant Table 2 Histological and morphological assessment of mouse stomach, small intestine and caecum following treatment with vehicle (CNTR) or antibiotics (ABX) downward shift of the concentration-response curve to carbachol and a consequent decrease in maximum response, Emax falling to about 50% of the CNTR value (N = 8 mice per group; Figure 3A ). Ileal muscular response to the depolarizing agent KCl (60 mM) was also significantly decreased in ABX-treated mice (N = 8 mice per group; Figure 3B ). To confirm that ileal contraction changes in ABX-treated mice were caused by alterations in neuromuscular function, we evaluated the effect of EFS at increasing frequencies of stimulation on ileal preparations. In ABX-treated mouse ileum, the EFS-elicited contractions significantly decreased, by about 60% of the CNTR value at 10 Hz (N = 8 mice per group; Figure 3C ), confirming development of alterations in the excitatory neurotransmission. We previously demonstrated that in mouse ileum, EFS-mediated responses to frequencies up to 10 Hz are of neuronal cholinergic origin, being sensitive to both tetrodotoxin and atropine . In ileal whole-mount preparations of ABX-treated mice, the number of AChE + myenteric neurons and ChAT immunoreactivity was significantly reduced compared with CNTR mice (N = 6 mice per group; Figure 3D -G), suggesting that the cholinergic neuronal network is significantly affected by microbiota dysbiosis.
Antibiotic-induced microbiota dysbiosis affects inhibitory neurotransmission
Subsequently, we evaluated the effect of microbiota dysbiosis on the enteric nitrergic transmission, which represents the main inhibitory neurotransmission on the intestinal neuromuscular function (Filpa et al., 2017) . NO-mediated relaxation responses of mouse ileum to transmural stimulation were evaluated in the presence of guanethidine and atropine, and the NO dependence of the relaxation was confirmed by incubation with the non-selective NOS inhibitor L-NAME prior to EFS (Zizzo et al., 2004) . NANC-evoked on-relaxations at 10 Hz stimulation frequency markedly increased in ABX-treated mice, compared with CNTR (by 70%, N = 8 mice per group; Figure 4A , B). In ABX mice, pretreatment with 1400 W, a selective inhibitor of iNOS, did not affect 10 Hz EFS-induced on-relaxations in NANC conditions ( Figure 4B ) whereas addition of L-NAME abolished the on-relaxation response induced by EFS in CNTR mice, but not in ABX-treated mice (N = 8 mice per group; Figure 4B ), suggesting enhancement of other inhibitory neurotransmitter pathways, after microbiota dysbiosis (Zizzo et al., 2003) . To further investigate the effect of dysbiosis on the enteric nitrergic neurotransmission, we evaluated the distribution of nitrergic Western blot analysis of nNOS in protein extracts from ileal segments from ABX and CNTR mice (N = 6 per group). β-actin was used as loading control. Protein signals were quantified using densitometry analysis. Data are reported as mean ± SEM. *P < 0.05, significantly different from CNTR;°P < 0.05, significantly different from respective control without L-NAME; one-way ANOVA followed by Newman-Keuls post hoc test (panel A), paired or unpaired Student's t-test (panel B) or or unpaired Student's t-test (panels D, E and F).
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neurons in the myenteric plexus. The number of nNOS + myenteric neurons was significantly reduced in the ileum of ABX-treated mice, compared with CNTR mice (N = 6 mice per group; Figure 4C -E). These changes were confirmed by the reduced nNOS protein levels in ileal samples from ABX-treated mice (N = 6 mice per group; Figure 4F ), suggesting the involvement of other NANC transmitters, such as vasoactive intestinal peptide or ATP, in providing the increased ileal relaxation, in spite of the reduction of nNOS + neurons (Caputi et al., 2017) .
Substance P neurotransmission sustains ileum smooth muscle contractility following antibiotic-induced microbiota dysbiosis
To assess the contribution of other non-cholinergic excitatory neurotransmitters to neuromuscular function, we evaluated post-stimulus excitatory off-responses under NANC conditions in the presence of L-NAME, to unmask tachykininergic nerve-evoked contractions (Lecci et al., 2006) . The tachykinin-mediated response was increased in ABX-treated mice (N = 5 mice per group; Figure 5A ) and this off-response was significantly reduced after selective blockade of NK 1 receptors with L732138 ( Figure 5A ). In parallel, immunostaining for SP, a member of the tachykinin family of neuropeptides, with higher affinity for NK 1 than for NK 2 or NK 3 receptors (Lecci et al., 2006) , increased about 1.9-fold in the muscularis externa of ileal frozen sections of ABX-treated mice, relative to preparations obtained from CNTR animals (N = 5 mice per group; Figure 5B , C). A proportional significant increase of SP + neurons was observed in ileal myenteric plexus of ABX-treated mice (N = 5 mice per group; Figure 5D -F).
Functional involvement of TLR2 in ABX-treated juvenile mice
Because the interaction between gut microbiota and the host is mediated through TLRs, which are expressed throughout the whole intestine (Brun et al., 2015) , we evaluated TLR2 immunofluorescence in ileal frozen sections and whole-mount preparations. Antibiotic treatment increased TLR2 immunoreactivity in myenteric ganglia of LMMP whole-mount preparations (N = 5 mice per group, Figure 6A , B) and in neuromuscular and mucosal layers of ileal cryosections (N = 5 mice per group, Figure 6C, D) . In ABX-treated mice, daily supplementation with the TLR2 agonist Pam3CSK4, given i.p., partly reversed the altered excitatory neuromuscular responses to carbachol (N = 8 mice per group; Figure 7A ) and EFS (N = 8 mice per group; Figure 7B ), suggesting that the gut microbial-and/or host-derived factors are involved in maintaining ENS homeostasis .
Discussion
The symbiotic microbiota of the mammalian gut plays a key role in the development and preservation of bowel neuromotor activity by promoting several crucial functions, including pathogen defence, nutrition and maturation of the enteric nervous and immune systems (Hansen et al., 2015) . We here show, for the first time, the consequences of microbiota dysbiosis on the structure and function of juvenile ENS and provide novel insights into the affected pathways. In particular, this study demonstrates that microbiota dysbiosis during early adulthood has the following outcomes: (i) slowing of GI transit; (ii) altered morphology of the enteric glial bundles as well as changes in cholinergic, nitrergic and tachykinergic neurochemical coding; (iii) dysmotility of the small intestine associated with impaired cholinergic and nitrergic neurotransmission, increased SP-mediated motor response via NK 1 receptors; and (iv) increased TLR2 immunofluorescence intensity in the neuromuscular layers. To confirm the microbiota-mediated effect on ENS development, we activated, pharmacologically, the TLR2 pathway and found that defects in excitatory motor responses were partly corrected by treatment with the TLR2-specific agonist Pam3CSK4.
A two week course of high-dose antibiotics is a costeffective model to assess the effects of gut dysbiosis on ENS integrity (Ubeda and Pamer, 2012 ). In our model, as in a germ-free phenotype, only the caecum and spleen showed macroscopic abnormalities. In addition, consistent with previous observations obtained after alteration of microbiota composition, gastric emptying and intestinal transit decreased, while the thickness of the muscularis externa in stomach, ileum and caecum increased, in ABX-treated mice (Barbara et al., 2005; Reikvam et al., 2011; Grasa et al., 2015) . Increased luminal levels of TCA were paralleled by the disappearance of CA in detectable levels, in ABX-treated mice. These findings were consistent with data from ampicillintreated and germ-free mice (Sayin et al., 2013) and confirmed the regulatory role of healthy gut microbiota in primary bile acid metabolism in the intestines. In agreement with other studies carried out in adult animals (Barbara et al., 2005; Reikvam et al., 2011; Brun et al., 2013; Theriot et al., 2016) , these observations emphasize that commensal stimulation plays a key role for juvenile gut homeostasis, including regulation of the motor function of the intestine. In mammals, young adulthood represents a critical and dynamic phase for differentiation and maturation of neural circuits in the gut (Collins et al., 2014) . Several developmental changes occur postnatally, in the ENS. Although maturation of neural and glial cells within enteric mammalian ganglia takes place within the first 2 weeks of life, the on-going adaptive integration of neuron-glia units into the three-dimensional complex architecture continues for several weeks after birth . In our study, microbiota dysbiosis after antibiotic treatment during early adulthood affected the assembly of enteric neural circuits, reducing the number of neurons in the myenteric plexus, in analogy with results obtained in germ-free mice, TLRs knockout mice or autoimmune disorders (i.e. TLRs overstimulation) (Okun et al., 2009; Brun et al., 2013; Collins et al., 2014) . In addition, distortion of GFAP + processes and S100β overexpression are highly indicative of myenteric glial network alterations, which may underlie gut gliopathy due to a disrupted host-bacteria crosstalk. Besides exerting a trophic and functional support to enteric neurons, EGCs have been identified as key cellular targets for intestinal microflora. However, in this latter regard, the molecular mechanisms by which luminal microbiota shapes the organization of enteric neuroglial networks and its potential implication in GI disorders remains to be elucidated (Turco et al., 2014; Kabouridis et al., V Caputi et al. 2015) . In ABX-treated mice, changes in ENS neurotransmitter pathways induced small bowel motor disturbances, resulting in a functional imbalance between excitatory and inhibitory neurotransmission. In vitro antibiotic treatment may alter gut neuromuscular contractility, either depressing the tone of isolated colonic muscularis mucosae, as with ampicillin, or potentiating cholinergic responses, as with vancomycin (Ceran et al., 2006) . However, our observations are in accordance with recently published studies suggesting that a dysbiosis, elicited in vivo by either antibiotic treatment or induced by either dietary changes or genetic deficiencies (i.e. TLRs deficiency), may either directly or indirectly affect gut motor and sensory function (Quigley, 2011; Brun et al., 2013) . In this respect, a reduction of nNOS + myenteric neurons together with an increased inhibitory neurotransmission, determined by the involvement of ATP pathways, has been observed in TLR4 À/À mice, suggesting a key role of microbial-derived stimulation for ensuring gut homeostasis (Caputi et al., 2017) .
BJP
In the present study, we showed that antibiotic treatment increased SP immunoreactivity in the ileal neuromuscular compartment. SP is described as enteric neurotransmitter involved in the modulation of the enteric motor and sensory functions, and its intestinal content may be affected by bacteria perturbation or low-grade inflammation resulting from antibiotic treatment (Verdú et al., 2006) . Detection of commensal bacteria by TLRs seems to represent an essential step to maintain the structural and functional integrity of ENS. Indeed, an impaired crosstalk between enteric commensals and TLRs may promote neurogliopathy, as observed in IBS and IBD (Frosali et al., 2015; Barbara et al., 2016) . Gut dysbiosis enhanced immunofluorescence TLR2 signal both in neuromuscular and mucosal layers, suggesting the occurrence of a disrupted host-microbe interaction. The findings obtained in the present study, involving antibiotic-induced changes in TLR2 expression, nitrergic and tachykinergic enteric transmitter pathways, are consistent with those obtained in a recent study evaluating the influence of TLR2 signalling on ENS morphology and function . In particular, up-regulation of TLR2 and SP pathways is all the more interesting because, in addition to its role in neurotransmission, SP can exert immunomodulatory activity and amplify innate immune responses by up-regulating TLR2 signalling (Tancowny et al., 2010) . The ability of a selective TLR2 agonist to restore excitatory motor responses after antibiotic treatment suggests that TLR2 stimulation by microbial-or/and host-derived factors can directly affect gut neuromuscular function. Consequently, we may infer from our data that an antibiotic therapy may reduce the availability of molecules, such as bacteria-derived lipopeptides, which via TLR2 activation retain a fundamental role in maintaining correct intestinal motor responses.
With the identification of the microbiota-gut-brain axis, it is tempting to propose that the morpho-functional defects observed in the ENS may set the basis for the phenotypic characteristics observed in a variety of diseases, ranging from depression and anxiety to IBS, obesity and neurodevelopmental disorders (Foster and McVey Neufeld, 2013; Crawford et al., 2015; Barbara et al., 2016; Bertrand et al., 2016; Milleit et al., 2016) . Detrimental effects may thus affect the microbiota-host dialogue after antibiotic-induced dysbiosis, as, by perturbing the maturation of commensal microbiota composition as well as ENS development, the risk of developing chronic diseases (e.g. Crohn's disease) could be potentially much higher, as reported in observational studies in children (Ungaro et al., 2014) . Although our findings suggest that alterations of intestinal microflora may exert harmful effects on ENS development, we also provide evidence that activation of TLRs signalling by specific natural or synthetic agonists or by probiotics may have beneficial effect by restoring ENS integrity.
In conclusion, our study showed that perturbations of microbiota composition and consequent dysregulated hostbacteria interaction during early adulthood were critical as they significantly hampered ENS maturation and potentially established a phenotype susceptible to IBS and/or IBD Ungaro et al., 2014; Barbara et al., 2016) . In addition, our findings also suggested that a 2 week high-dose course of antibiotics in juvenile mice represents a practical model for evaluating the effect of gut commensal bacteria on the maturation of juvenile ENS, without affecting the original postnatal gut microbiota composition, which is inevitable in germ-free mice. Finally, due to the emerging role of microbiota on gut activity and organization, and its potential relevance on gut functional disorders, further studies are needed to fully disclose the modulatory role of gut microbiota-derived factors on specific neurotransmission pathways and related effects on motility and pain perception, which may possibly predispose to gut disorders or preserve ENS developmental integrity.
Figure 7
Pam3CSK4 administration improves excitatory neuromuscular contractility in ABX-treated mice. Concentration-response curves to (A) carbachol (CCh) and EFS-induced contractions (B) in isolated ileal preparations from CNTR, ABX-treated mice and ABX-treated mice after daily administration of Pam3CSK4 (N = 8 mice per group). Data are reported as mean ± SEM. *P < 0.05, significantly different from CNTR;°P < 0.05, significantly different from ABX-treated mice; two-way ANOVA followed by Bonferroni's post hoc test (panels A and B). Theriot CM, Bowman AA, Young VB (2016). Antibiotic-induced alterations of the gut microbiota alter secondary bile acid production and allow for Clostridium difficile spore germination and outgrowth in the large intestine. mSphere 1 e00045-15.
